决定异体 CAR T 细胞排斥与扩增的细胞和分子机制
Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.
我们评估了11例接受单一批次cemacabtagene ansegedleucel(cema-cel)治疗的大B细胞淋巴瘤患者,cemacabtagene ansegedleucel是一种异体抗CD19 CAR T产品。
英文原题:Extranodal NK/T-cell lymphoma, nasal type, presenting as a necrotic palatal ulcer.
免疫组化染色显示LCA和CD3弥漫表达,CD30局灶表达,CD20、ALK和CD56表达缺失,增殖活性高,Ki-67指数约为90%。
结外NK/T细胞淋巴瘤(ENKTL),鼻型,是一种侵袭性EB病毒(EBV)相关淋巴瘤,主要累及鼻腔和上呼吸消化道。原发性口腔表现罕见,临床上可能类似于良性炎症或感染性疾病,导致诊断延迟。本报告呈现一例罕见的ENKTL,最初表现为快速进展的坏死性腭部溃疡。一名44岁男性,表现为后硬腭坏死性溃疡三周病史。影像学显示广泛的面中部破坏,包括腭部穿孔、鼻中隔侵蚀、鼻甲破坏、筛窦受累及眶内侧壁延伸。组织病理学检查显示非典型大淋巴细胞,伴广泛坏死并浸润脂肪和肌肉组织。免疫组化染色显示LCA和CD3弥漫表达,CD30局灶表达,CD20、ALK和CD56表达缺失,增殖活性高,Ki-67指数约为90%。基于组织形态学和免疫表型特征,怀疑为结外NK/T细胞淋巴瘤。EB病毒编码RNA(EBER)的显色原位杂交(CISH)显示非典型淋巴细胞核强阳性,确诊为ENKTL,鼻型。患者化疗后达到完全缓解;然而,八个月后,患者出现全身性复发,诊断为外周T细胞淋巴瘤。本病例突出了ENKTL表现为破坏性腭部病变时的诊断复杂性。全面的组织病理学评估、详细的免疫表型分析以及通过 EBER 确认 EBV 对于准确诊断和及时的肿瘤学管理至关重要。在常规治疗无效的快速进展性口腔坏死性病变的鉴别诊断中,应考虑 ENKTL。
Extranodal natural killer/T-cell lymphoma (ENKTL), nasal type, is an aggressive Epstein-Barr virus (EBV)-associated lymphoma that predominantly involves the nasal cavity and upper aerodigestive tract. Primary oral manifestations are rare and may clinically mimic benign inflammatory or infectious conditions, resulting in delayed diagnosis. This report presents a rare case of ENKTL initially manifesting as a rapidly progressive necrotizing palatal ulcer. A 44-year-old man presented with a three-week history of a necrotic ulcer on the posterior hard palate. Imaging revealed extensive midfacial destruction, including palatal perforation, nasal septal erosion, turbinate destruction, ethmoidal involvement, and medial orbital wall extension. Histopathologic examination demonstrated atypical large lymphoid cells with extensive necrosis and infiltration into adipose and muscle tissue. Immunohistochemical staining demonstrated diffuse expression of LCA and CD3, focal expression of CD30, absence of CD20, ALK, and CD56 expression, and a high proliferative activity, as evidenced by a Ki-67 index of approximately 90%. Based on the histomorphologic and immunophenotypic features, extranodal NK/T-cell lymphoma was suspected. Chromogenic in situ hybridization (CISH) for Epstein-Barr virus-encoded RNA (EBER) demonstrated strong nuclear positivity in atypical lymphoid cells, confirming the diagnosis of ENKTL, nasal type. The patient achieved complete remission after chemotherapy; however, eight months later, the patient developed a systemic relapse that was diagnosed as peripheral T-cell lymphoma. This case highlights the diagnostic complexity of ENKTL presenting as a destructive palatal lesion. Comprehensive histopathologic evaluation, detailed immunophenotyping, and EBV confirmation by EBER are essential for accurate diagnosis and timely oncologic management. ENKTL should be considered in the differential diagnosis of rapidly progressive oral necrotic lesions unresponsive to conventional therapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。